IEEE Computer Society and GBC/ACM
online 7:00 PM, Thursday, 24 February 2022
Cell Development Kits (CDKs) - SDKs for Biology
Patrick Boyle, Ginkgo Bioworks
Register in advance for this webinar at https://acm-org.zoom.us/webinar/register/9016427351252/WN_JeYRu9ZCSmiDPbyf4IVsEQ
After registering, you will receive a confirmation email containing information about joining the webinar.
Patrick Boyle is the Head of Codebase at Ginkgo Bioworks, a Boston-based synthetic biology company that makes and sells engineered organisms. Ginkgo is the leading horizontal platform for cell programming - we use automation and software to program DNA code. In this context, Ginkgo’s “Codebase” is our portfolio of reusable biological assets. Ginkgo's Codebase includes thousands of novel strains, enzymes, genetic parts, and diverse genetic repositories, including millions of engineered DNA sequences. To help more developers leverage Ginkgo’s Codebase, we recently launched “Cell Development Kits” (CDKs) - our version of SDKs.
CDKs provide streamlined access to the company’s platform for aspiring cell developers to program cells to tackle the biggest challenges facing society. The first CDKs to launch are focused on protein expression programs. The service provides developers access to the toolkit needed to get started developing commercial proteins, including pre-engineered host cells optimized for protein production, specialized equipment, automation capabilities, genetic engineering expertise, insights garnered from Ginkgo’s codebase and the applicable infrastructure to design, build and test a custom microbe.
Ginkgo’s CDKs are designed to cut the cost of launching a cell program and speed up development timelines to build engineered microbes, for example, to determine whether a protein may be successfully and commercially produced. The service is also designed to enable customers to prototype their idea in phases, with each phase providing data that can inform the customer’s project and business strategy. By simplifying the pathway for companies to get started on the Ginkgo platform with standard terms, a phased approach, low costs—starting at $100,000 for protein expression projects—and clear deliverables, the CDK can help derisk projects prior to full scale technical development.
This joint meeting of the Boston Chapter of the IEEE Computer Society and GBC/ACM will be online only due to the COVID-19 lockdown.
Up-to-date information about this and other talks is available online at https://ewh.ieee.org/r1/boston/computer/. You can sign up to receive updated status information about this talk and informational emails about future talks at https://mailman.mit.edu/mailman/listinfo/ieee-cs, our self-administered mailing list.
Updated: Jan 24, 2022--webbot bot="TimeStamp" i-checksum="16995" endspan -->.